Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone Low-Dose - High-Dose Study Study

ClinicalTrials.gov ID: NCT01821378

Public ClinicalTrials.gov record NCT01821378. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Low-dose Lurasidone in Acutely Psychotic Subjects With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in subjects with an acute exacerbation of schizophrenia.

Study identification

NCT ID
NCT01821378
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
412 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2013
Primary completion
May 31, 2014
Completion
May 31, 2014
Last update posted
Jul 20, 2016

2013 – 2014

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
Woodland International Research Group, Inc. Little Rock Arkansas 72211
Comprehensive Clinical Development Cerritos California 90703
Synergy Clinical Research of Escondido Escondido California 92025
Apostle Clinical Trials, Inc. Long Beach California 90813
Cnri, Llc Los Angeles California 90660
Pasadena Research Institute Pasadena California 91106
Cnri, Llc San Diego California 92102
University of California San Diego Medical Center San Diego California 92103
Collaborative Neuroscience Network, Inc. Torrance California 90502
Western Affiliated Research Institute Denver Colorado 80209
Florida Clinical Research Center, LLC - PARENT Maitland Florida 32751
University of Miami Medical Center Miami Florida 33136
Florida Clinical Research Center, LLC Orlando Florida 32810
Atlanta Center for Medical Research Atlanta Georgia 30308
iResearch Atlanta, LLC Decatur Georgia 30030
Via Christi Research, a division of Via Christi Hospitals Wichita, Inc. Wichita Kansas 67214
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629
Center for Behavioral Health, LLC Rockville Maryland 20850
St. Charles Psychiatric Associates Saint Charles Missouri 63301
Midwest Research Group Saint Charles Missouri 63304
Neurobehavioral Research, Inc. Cedarhurst New York 11516
Comprehensive Clinical Development- Holliswood Hospital Holliswood New York 11423
Midwest Clinical Research Center, LLC Dayton Ohio 45417
CRILifetree Philadelphia Pennsylvania 19139
FutureSearch Clinical Trials, L.P. Austin Texas 78731
FutureSearch Trials of Dallas, LP Dallas Texas 75231
Pillar Clinical Research, LLC Dallas Texas 75243
Bayou Clinical Research, Ltd. Houston Texas 77007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01821378, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2016 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01821378 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →